Merck MRK announced that the FDA has granted breakthrough therapy designation (BTD) to sacituzumab tirumotecan (sac-TMT) for ...

A RECENT study examining the impact of airflow limitation (AL) on lung cancer (LC) screening outcomes suggests that the ...

Precision medicine in the context of lung cancer represents a transformative approach that integrates prevention, diagnosis, and treatment tailored to individual patient differences. This field ...

The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed by Cancer Research UK-funded scientists from UCL and The Francis Crick ...

Merck's (MRK) antibody drug conjugate sac-TMT has received FDA Breakthrough Therapy designation for the treatment of EGFR-mutated lung cancer. Read more here.

The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed ...

This page includes links to articles highlighting the top lung cancer research published on Cancer Therapy Advisor in 2024.

Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

Americans will be diagnosed with lung cancer in their lifetime. "If you can find it earlier, we know outcomes are so much ...

Luye Pharma Group (HK:2186) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...